Industries > Pharma > Anastomosis Devices Market Report 2019-2029

Anastomosis Devices Market Report 2019-2029

By Product (Disposable, Reusable), by Application (Cardiovascular Surgery, Gastrointestinal Surgery), by Region, Competitive Landscape and Segment Forecasts

PUBLISHED: 30 August 2019
PAGES: 177
PRODUCT CODE: PHA0505
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0505 Categories: , Tag:

Anastomosis Devices are used in performing surgeries for CHD/CAD (Coronary Heart/Artery Disease), gastrointestinal surgeries, orthopedic, ophthalmic surgeries. These devices can be disposable or reusable and offer advantages of reduced chances of vessel leakage, stenosis, and occlusion as compared to conventional procedures.

Market Overview and Trends
Disposable anastomotic devices will dominate the market due to wide product offering of various market players. Also, cardiovascular surgery will drive the market given the rising prevalence of CHD and increasing number of CABG procedures across the countries.

As per geographical breakdown, North America will be the dominant market due to presence of well-structured reimbursement policies, widening base of target population, and local presence of a large number of key players. Asia Pacific will see the maximum growth due to growing geriatric population, rising incidence of CVD, rapid developments in the healthcare sector, and increasing disposable income.

Factors Influencing the Market Growth:
• Rising prevalence of cardiovascular and gastrointestinal diseases
• Swelling demand for Coronary artery bypass grafting (CABG)
• Reduced risk associated with surgery
• Increasing geriatric population
• Growing number of people who need re-operations after 10 to 12 years from their first bypass surgery
• Presence of favourable reimbursement structure in developed countries

Factors Restraining the Market Growth:
• Complications related to anastomotic procedures
• Anastomosis devices are classified as class II medical devices and regulatory framework is not very stringent.
• High Competition is expected in near future

Market Segmentation 2019-2029:
The Anastomosis Devices market is segmented by Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By Region, Competitive Landscape, and Segment Forecasts.

Market Segmentation Covered:
• Global Anastomosis Devices Product Type Market 2019-2029
• Global Disposable Market 2019-2029
• Global Reusable Market 2019-2029
• Global Anastomosis Devices Application Market 2019-2029
• Global Cardiovascular Surgery Market 2019-2029
• Global Gastrointestinal Surgery Market 2019-2029
• Global Others Market 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Anastomosis Devices market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Medtronic; LivaNova PLC; MAQUET Holding B.V. & Co. KG.; Dextera Surgical Inc.; Vitalitec Internaional Inc.; Synovis Micro Companies Alliance, Inc.; and Ethicon US, LLC.

Key questions answered by this report:
• What is the current size of the total global Anastomosis Devices market?
• How much will this market be worth from 2018 to 2029?
• How is the Anastomosis Devices market evolving?
• What is driving and restraining the Anastomosis Devices market?
• What are the market shares of each segment of the overall Anastomosis Devices market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Anastomosis Devices market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Anastomosis Devices market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Anastomosis Devices market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Anastomosis Devices market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Anastomosis Devices market. You find data, trends and predictions.

Buy our report today Anastomosis Devices Market 2019-2029: By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By Region, Competitive Landscape, and Segment Forecasts.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Anastomosis Devices Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Anastomosis Devices Market Report 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category